Brain Scan Breakthrough Helps Predict

Bi Board

Look out for these Upcoming Issues 2006 Australia Brain Scan Breakthrough Helps Predict Schizophrenia University of Melbourne researchers have become the ﬁ rst in the world to show that brain scans can be used to predict how well young people will recover from early 15 Nov Special Issue on psychotic episodes that occur in mental illnesses such as Clinical Trials in Asia Paciﬁ c schizophrenia.

30 Nov Biostatistics A team from the University’s Melbourne Neuropsychiatry Center (MNC) and ORYGEN Research Center has made the breakthrough. Their research shows that levels of a certain 15 Dec Lipodomics chemical in the brain can predict how a young person experiencing their ﬁ rst psychotic episode is likely to be 30 Dec Special Issue on affected over the next few years. The Melbourne scientists Bioinformatics in Asia Paciﬁ c compared the brain scans of 46 psychiatric patients with their health records over two years.

The researchers used a technique known as MR spectroscopy, in which MRI scans are used to measure the concentration of chemicals in the brain. Findings of the research are published this month in the international journal the Archives of General Psychiatry.

International Bio Partnering The Victorian Government has engaged a biotechnology industry consultant, Intersuisse Bioscience, to help build Victoria’s proﬁ le as a world-class biotechnology center and to encourage European biotechnology companies to invest in Victoria.

Intersuisse Bioscience will act as an international facilitator to bring international companies (focusing on those in Europe and the UK) into useful contact with those in Victoria, such that new commercial collaborations are created and developed. Bi Board

New Generation Heart Assist effective monitoring and licensing framework to Devices Show Promise for prevent improper and unacceptable practices and continue a range of prohibitions including the ban Patients on reproductive cloning. Australian heart assist device company Sunshine Heart, Inc has revolutionize treatment options for patients with congestive heart failure with its new Peter Maccallum Cancer Center discovery of heart assist devices which will be free and Affymetrix Initiate Five-Year of external attachments. Congestive heart failure is Research Collaboration a progressively worsening condition characterized Affymetrix Inc. announced that it has entered into by shortness of breath with mild exercise, fatigue, five-year collaboration with the Peter MacCallum dizziness and fluid retention. Cancer Centre to analyze genomic information across Sunshine Heart’s C-PulseTM is an implantable, non- large patient samples. Under terms of the agreement, blood contacting heart assist device for the treatment Peter Mac researchers will use Affymetrix GeneChip® of people with heart failure. The C-PulseTM has been microarray technology for translational research designed to increase blood supply to both the body projects, beginning with studies on ovarian cancer and the heart itself, simultaneously reducing the and carcinoma of unknown primaries. Peter Mac strain on the heart and relieving patient’s symptoms. researchers will use Affymetrix GeneChip technology The C-PulseTM is aimed at patients with moderate to to perform large-scale clinical studies. The Affymetrix severe heart failure and because it does not come into technology will enable them to more rapidly discover contact with blood, the risk of clotting and bleeding RNA and DNA patterns that can better classify, complications are reduced and the device is safe to manage and treat complex diseases. turn on and off as desired. Sunshine Heart is working with the Allegheny- Portland Orthopaedics’ $360K Singer Research Institute (ASRI) in Pittsburgh, USA US Hip order to evaluate the feasibility of using Allegheny’s unique Portland Orthopaedics Limited has received its muscle energy converter (MEC) to power the C-PulseTM third order from US distributor Plus Orthopedics heart-assist device. Researchers at ASRI have invented Inc with the new order requesting a further A$360,000 a completely self-contained hydraulic pump that of primary hip replacements for immediate delivery. requires no external power source. Called a muscle This is Portland’s second order for the M-COR primary energy converter, or MEC, the device turns skeletal hip. The three orders over three months totals A2.47 muscles into living batteries, harnessing their vast million compared to total sales in the year to June stores of mechanical energy to power an implant. Once 2006 of A$1.63 million. Portland’s M-COR primary situated in the chest, the titanium device is fastened hip replacement is fixed in the thigh bone (femur) to the rib cage. with traditional hammering familiar to orthopaedic surgeons. The M-COR is a modular design with Patterson Tables Embryonic Stem a distinct neck component for improved fit and Cell Bill adjustability. Portland has moved to full capacity manufacturing and is taking measures to licence off- Liberal backbencher, Senator Kay Patterson. site manufacturing to improve inventories. tabled her promised private member’s bill on embryonic stem cell research and therapeutic cloning. “Demand from Plus Orthopedics is exceeding The proposed amendments to current legislation expectations as the first US surgeons are choosing to outlawing therapeutic cloning closely follow the implant more M-COR hips than we expected,” said recommendations of the Lockhart Review. Patterson Mr David Sekel, CEO of Portland Orthopaedics. said the amendments would maintain a strong and “Portland’s priority is to immediately boost Bi Board

manufacturing capacity to meet the expanding joint R&D to commercialize its MD Keeper wrist replacement range and meet the growing demand.” device that can monitor patients’ physical information Professor Colin Masters Receive • ALS Drug Compound Delivery • Neusrosciences Victoria and Israel’s Shizim the Lewis K. Black International are collaborating to develop a new way Prize to treat motor neurone disease, Amyotrophic Professor Colin Masters, of the Department of Lateral Sclerosis (ALS) Pathology, University of Melbourne and co-founding • Interactive Health and Wellbeing Portal scientist and Director of Prana Biotechnology Limited • Victorian company Health First and Israel- will receive the Lewis K. Black International Prize based Card Guard are developing an in-home for Excellence in Biomedical Research, presented blood glucose monitoring system with wireless by Thomas Jefferson University. The Lewis K. Black data transmission to a central database International Prize in Medicine is awarded biennially • Dairy Farming Practices Software in recognition of the impact, either accomplished or • Victorian company, Milka-Ware and Israeli potential, of pioneering biomedical research on the based Afikim are developing strategic software alleviation of human disease and suffering. that measures and analyzes milking variables in order to improve the productivity of dairy farms “Professor Masters’ receipt of this prestigious award offers further validation of the absolute credibility of the Prana scientific team,” said Geoffrey Victorian Medical Research Kempler, Chairman and Chief Executive Officer of Institutes Receive A $26M Boost Prana Biotechnology. “For over 30 years, Colin has The Victorian Government announced A$26 dedicated his research to the study of the nature million for 15 Victorian medical research institutes of Alzheimer’s disease with the hope of finding an through the Operational Infrastructure Support effective treatment.” Program (OISP). The infrastructure grants support His current research studies on Alzheimer’s the laboratories, equipment and facilities that are disease are focused on identifying compounds, such vital to achieving Victoria’s breakthroughs in medical as PBT2 (Prana’s lead compound), that can inhibit research. Minister Brumby used the announcement to the production or aggregation of amyloid in the highlight the work undertaken by the Ludwig Institute Alzheimer’s diseased brain. PBT2 is scheduled to for Cancer Research (LICR), one of the beneficiaries commence a Phase II clinical trial in Sweden. of the OISP and the Royal Melbourne Hospital. The team has been analyzing clinical records on 1,500 bowel cancer patients collected in the Bio21 Molecular Victorian and Israeli Companies Medicine Informatics Model (MMIM) database. Announce Collaborations The MMIM was established in 2002 and is being On 19 September the Minister for Innovation, rolled out across all Victorian metropolitan and Mr Brumby announced A$1 million for regional cancer centres to develop the Australian commercialization collaborations between Victorian Cancer Grid with A$11 million State funding and Israeli companies. The four projects to be funded announced in Healthy Futures Life Science Statement under VISTECH include: launched in April 2006. • Victoria-Israel Telehealth Expert System Through the database, researchers have identified (VITEX) new information about links between: • Tadiran Lifecare an Israeli company has • Diabetes and bowel cancer; teamed with Melbourne-based Siemens • Treatment of non-English speaking people and Australia, to undertake clinical trials and further cancer; Bi Board

• The age of patients and treatments they in China. China’s first official database for academic receive and journals became operational recently. A key national • Diet, lifestyle factors and cancer. web project, the search program built at a cost of 345 million yuan US$43 million provides the contents of 6,642 periodicals, or 99 percent of Chinese academic China periodicals that are used as sources by researchers at Advances in Agriculture in China home and abroad. Going beyond academic periodicals, over the next five years China will build a huge The Northeast China Agricultural University database called the national database of knowledge (NCAU), the Harbin Municipal Science & Technical resources. Netizens will be able to carry out an internet Bureau and their cooperative unit announced their search on all kinds of academic documents. The successful cloning of local pigs with the use of somatic project is being undertaken by Qinghua University and cells recently. Three cloned baby pigs have been doing the Qinghua Tongfang Internet Technology Co. Ltd. well and normally since their birth on October 12. Dr. Liu Zhonghua, leader of the project who comes from the Life Science College of the NCAU, acknowledged China Proposes Plan to Curb that the three cloned baby pigs, unlike pigs cloned Emissions of SO2 in the past, had taken somatic cells from a three-day China is renewing its promise to reduce sulphur old piglet as donor cells. The Northeast China local dioxide emissions, with a plan that would see power pigs, noted for being reproductive and adaptable with plants paying for, and trading, the right to emit the a good meat quality, are a leading fine breed under pollutant. A similar trading market in the United the state protection. States, established under the country’s Environmental Protection Agency, has had a huge impact, reducing Application Guidelines Issued for emissions of the acid-rain-causing gas by 31% Projects in the 863 Program between 1993 and 2002. Recently, MOST has issued the guidelines for So far, China’s attempts to lower pollution application for projects in part of the sectors of 863 emissions have failed, according to a government Program. The guidelines were prepared according to report released. Instead of the 10% sulphur dioxide the Outline of the National Medium and Long-term reduction they had planned for 2001 to 2005, S&T Development Plan, the National S&T Development emissions jumped up 27% over this period. Plan in the Eleventh Five-Year Plan Period and the Development Outline of the High-Tech Research and That makes China the world’s largest sulphur Development Program of China (863 Program) in the dioxide emitter, pumping out 25.5 million tonnes of Eleventh Five-Year Plan Period. The guidelines issued the gas in 2005 (compared to US emissions of roughly relate to 21 projects in five sectors, namely, biological 15 million tonnes). According to Xinhua News Service, and medical technology, resources/environmental the official government news provider, one-third technology, ocean technology, modern agriculture of the country “was bathed in acid rain last year”. technology, and modern transportation technology. The State Environmental Protection Agency estimated RMB500 billion (US$63 billion) in related economic losses. China’s First Official Database Now the country is taking a shot at a revised goal, for Academic Journals hoping to reduce emissions by 10% from 2006 to Readers from anywhere in the world can now 2010. Cutting sulphur dioxide emissions could have a log on to the www.cnki.net website to search for warming effect on the planet these particles currently almost any important academic periodical published reflect sunlight back into space. But fears about Bi Board

respiratory and cardiovascular disease, ecological The US delegation held talks recently with Shang impact, and harm to crops are deemed to outweigh Yong, Vice Minister of Science and Technology and Bai this concern. Chunli, Executive Vice President of Chinese Academy of Sciences. The two parties concluded a memorandum on bilateral co-operation in nanotechnology, agreeing Chinese Scientist Meet to Discuss to enter into deeper cooperation in the future in joint Ground Water Management research and establishment of joint labs. They will More than 240 scientists from 56 countries will also cooperate to expand channels to commercialize soon gather in Beijing to discuss groundwater and nanotechnology. Mr. Cresanti and his delegation propose strategies for groundwater management. will also visit nano laboratories in Tianjin, Shanghai The 34th Congress of the International Association and Hangzhou, where they will have discussions on of Hydrogeologists (IAH), to be held in Beijing from ﬁnancing issues of the technology. Monday to Friday, will discuss groundwater quality, groundwater safety and contamination recovery, and Current Agriculture Research in groundwater management in the context of rural and urban development. China Through research and development of key Groundwater is any water found below the land technologies of modern agriculture under the 863 surface. It exists almost everywhere underground, for Program in the Tenth Five-year Plan period, China example in the space between particles of rock and soil established and improved the technical system of or in crevices and cracks in rock. Representatives from molecular detection and drug-resistance diagnosis United Nation agencies with important groundwater against pests of major plants, providing the technology programs will make presentations. guarantee for early warning and effective control of “The congress is an important forum for China to pests. learn groundwater management from other countries,” Against over 10 kinds of foreign quarantine pests said Yin Yueping, member of the organizing committee and major pathogens in China, on the basis of research of the congress. into the biological genome and functional gene of The congress will promote the survey, assessment, pathogens, the project: utilization, protection and management of groundwater a. developed the drug-resistance related gene in China and its role in sustainable social economic clone technology and design technology; development, Yin said. The congress has been b. established the technical platform for the organized by the IAH and the Ministry of Land and molecular detection and drug-resistance Resources. molecular diagnosis of plant epidemic diseases; c. set up the assembling and mass production China and U.S. Cooperate in flow and technological process for the Nanotechnology molecular detection reagent kit for detection A nanotechnology delegation from the United States and drug-resistance diagnosis of plant epidemic visited China recently to study the commercialization diseases; of nanotechnology in China. The delegation was d. and assembled and developed a batch of lead by Mr. Robert Cresanti, Under Secretary for molecular detection reagent kit that can be used Technology, United States Department of Commerce. for port inspection and quarantine. Bi Board

Five Scientists Awarded China’s India Highest Aerospace Honor Ranbaxy Hungry for Growth On the occasion of the 50th anniversary of China’s Malvinder Mohan Singh said Ranbaxy Laboratories aerospace industry, China Aerospace Science and Ltd plans to make more acquisitions at home, in Industry Corporation (CASIC) held a ceremony to Europe and in the United States. And is poised to give fi ve senior space experts what has been called boost its market share. He added, “We are aggressive the “highest honor in the history of China’s Aerospace and hungry for growth, the Indian market won’t Industry.” The fi ve experts are Qian Xuesen, Ren fulfi ll our aspirations.” Ranbaxy already generates Xinmin, Tu Shoue, Huang Weilu and Liang Shoupan. 80 per cent of its sales outside India and hopes to be Another group of space experts were given awards one the of top fi ve generic drug makers in the world by CASIC; Zhong Shan and 32 other experts were by 2012 by making cheaper versions of blockbuster given an award for an “outstanding contribution to drugs such as Lipitor, an anti-cholesterol medicine China’s space program over the last 50 years.” Shi made by Pfi zer Inc. Luguang and 73 other experts were recognized as having made a “signifi cant contribution to China’s Aerospace Industry in the as 50 years.” The leader of CASIC said that China Aerospace Science and Industry South Korea Corporation is now doing important research into the development of key weapons. It hopes the new Daiichi Pharmaceutical generation of astronauts will learn from the award Korea to Become Wholly recipients, give priority to national interests, and make Owned Subsidiary of Daiichi great contributions to China’s national defense and Pharmaceutical Co Ltd aerospace program. Daiichi Sankyo Company, Limited has announced that its subsidiary Daiichi Pharmaceutical Co, Ltd, has Food Poisoning Hits 200 Students signed an agreement to acquire 100% of shares in in Inner Mongolia Daiichi Pharmaceutical Korea Co, Ltd, a joint venture with Jeil Pharmaceutical Co, Ltd. The acquisition will About 200 students from a middle school in the take effect in October this year, when KDP becomes a Inner Mongolia Autonomous Region have been struck wholly owned Daiichi Pharmaceutical subsidiary. By with food poisoning after eating at their school. The making KDP a wholly owned subsidiary of Daiichi public security bureau of Fengzhen City said students Pharmaceutical, the Daiichi Sanyko Group plans to at the Experimental Middle School of Fengzhen City actively expand its business operations throughout developed symptoms such as dizziness, headaches, Asia. fever, vomiting and diarrhea in the morning and by early evening 82 students had been admitted to hospital. An investigation by health offi cials showed that food prepared for the students at their school was mixed with days-old food that had turned bad. Local police detained seven administrative workers from the canteen. The city government has suspended school principal, Suo Jianmin, who may face further disciplinary action. Bi Board

MALAYSIA Lieutenant-General (NS) Lim Chuna Poh will take over him as the A*star’s deputy chairman soon. Ranbaxy Launches the First Generic Atorvastatin in Malaysia US Cancer Clinic Sets up Shop in Ranbaxy Laboratories Limited, announced that the company’s wholly owned subsidiary, Ranbaxy Singapore Malaysia Sdn Bhd. (RMSB), has launched the first Singapore has become a venturing ground not only generic Atorvastatin, under the brand name, ‘Storvas,’ for foreign patients but also for medical providers. in Malaysia. The product introduced on-day-one, West Clinic, a cancer center in Tennessee, the United will be made available through all major GP’s States, has just sent a doctor and one nurse to provide (General Practitioners), Pharmacies and Hospitals cancer care in Singapore. It will increase its staff here in Malaysia. Storvas will be sold in dosage forms when the business grows. This is its first venture of 10mg, 20mg and 40mg. outside the US. While not in the big league like Johns Hopkins, which provides cancer treatment at Earlier in July 2006, RMSB became the first Tan Tock Seng Hospital. company to receive approvals to market generic Oseltamavir and was awarded a contract for supply Dr Lee Schwartzberg, medical director of West to the Malaysian government. The product marketed Clinic, said a major reason for coming to Singapore is under the brand name, Fluhalt, is an antiviral used the ability to extend these trials, which are needed by for treatment of H5N1 virus and is available in dosage pharmaceutical companies to prove the value of their form of 75 mg capsules. Fluhalt is being supplied to new drugs. He added, “Increasingly, drug development all government hospitals, clinics and pharmacies in has become a global enterprise.” Dr Steve Tucker, Malaysia. the oncologist who is based here, assured patients they will not be put at risk if they take part in such Commenting on the launch, T. Jeyabalan, trials. Any trial drug will be given on top of standard Managing Director, RMSB, said, “Ranbaxy is proud to cancer care. be the first Company to launch the generic alternatives of Atorvastatin and Oseltamivir in Malaysia. It is our constant endeavor to offer affordable and safe generics of high quality to the patients in Malaysia Taiwan and provide support to the government’s healthcare ADImmune Seals Deal on plan.” Cell Biotechnology Crucell NV, the largest Dutch biotechnology company, has agreed to share its large-scale cell Singapore manufacturing technology with a Taiwanese Mr Phillip Yeo Springs over to competitor. ADImmune Corp intends to use the PER.The C6 cell line to develop and commercialize Spring Singapore a vaccine against Japanese encephalitis virus in Top Biomedical , Mr Phillip Yeo will switch from Taiwan and China, the Leiden, Netherlands-based chairman of the Agency for Science Technology and Crucell said in a statement recently. Crucell licenses Research (A*star) to head the Standards Productivity technologies to companies such Merck & Co and and Innovation Board (Spring Singapore). Mr Yeo, a Koninklijke DSM NV and develops vaccines and Colombo Plan Scholar with and MBA from Harvard, antibodies that prevent and treat infectious diseases, will assume the new position in April next year. including influenza and malaria. In the statement, The civil servant is known for his contributions to Crucell said ADImmune will pay a license issuance Singapore’s economic development and life sciences. fee, annual maintenance fees and royalties on The Education Ministry’s permanent secretary future product sales. Bi Board

Taichung-based ADImmune, formerly known as in March, 2000 giving Genzyme the exclusive Kuo Kwang Serum and Vaccine Laboratories, was rights to develop and commercialize Synpac’s formed in 1965 through the technical support of enzyme replacement therapy for Pompe disease. Japanese vaccine developer Kitasato Institute. The Pompe disease damages the human heart, lungs and company is currently the only closely held human- skeletal muscles due to the accumulation of glycogen use vaccine manufacturer in Taiwan, according in tissues caused by the lack of an enzyme needed to to ADImmune’s Web site. With a pool of some 70 break down glycogen into glucose, the primary source employees, ADImmune has been receiving grants of energy in the human body. The enzyme is called from the Ministry of Economic Affairs to develop new alpha-Glucosidase. technology and products since 1998. The company has engaged in collaboration with Possible New Lung Cancer Marker several research institutes in Taiwan, including the Discovered Development Center for Biotechnology, to develop plasmid DNA manufacturing processes. A team of researchers from Taiwan recently announced that through a study of 80 lung cancer Recently, the company received investment patients, they found that lung cancer cells were over- funding of NT$512 million (US$16 million) expressing a particular protein, meaning that this from the Cabinet’s Development Fund, which is protein could be considered a new lung tumor marker. equal to approximately 21 percent of the post- The findings also had implications for the treatment of money stake. The company produces Japanese the deadly cancer, according to the scientists involved. encephalitis vaccine and tetanus toxoid, with the former commanding 100 percent of the local The researchers were headed by Dr. Shih Neng-yao, market and the later 50 percent of the market. principal investigator of the Institute of Cancer Research at the National Health Research Institutes (NHRI); Dr. Liu Ko-jiunn, also a researcher at the China Synthetic in US$ 821 Million Institute of Cancer Research; and Dr. Chang Gee-chen, Drug Royalty Agreement visiting staff member of the Department of Chest Medicine, Veterans General Hospital, Taichung Branch. In the biggest drug royalty agreement ever involving a Taiwanese company, a U.S.-based The team studied 80 lung cancer patients in subsidiary of China Synthetic Rubber reached a Taiwan and found a high incidence of the over- 15-year royalty sharing deal valued at up to US$821 expression of the p48EN01 protein in cancer million recently. Synpac (North Carolina) Inc. of cells. Additionally, patients with high levels of Research Triangle Park agreed on royalty payments p48EN01 showed a lower five-year survival rate. with Genzyme Corp. of Cambridge, Mass. over The researchers reported that this indicated that Myozyme, a drug therapy used to fight Pompe disease. p48EN01 could be considered a significant tumor marker for the early diagnosis of lung cancer. The deal will pay Synpac between US$423 million and US$821 million over 15-years, depending on the success In the course of the research, Shih identified two of the drug, China Synthetic said in a statement to the lung cancer-related proteins—p48EN01 and p120—as Taiwan Stock Exchange. The company said Myozyme well as two ovarian cancer-related proteins, by a has received approved for use in the U.S. and Europe. series of biochemical techniques. Studies showed The drug itself consists of the human enzyme acid that p48EN01 had the greatest correlation with the alpha-glucosidase (GAA), which is encoded by the cancer cell. Related animal experiments showed most predominant haplotype of the gene, according animals had higher immunity after being vaccinated to Genzyme. Myozyme is produced using recombinant by p48EN01 protein, meaning that p48EN01 DNA technology in a Chinese hamster ovary cell line. was not only a powerful tumor marker, but also Synpac and Genzyme originally reached an agreement an ideal target for immunotherapy treatment. Bi Board

SRI International to Conduct entered clinical trials, with several more currently Preclinical Studies of Cancer undergoing preclinical evaluation. Marketed examples of these drugs include bexarotene and halofantrine. Drug for Taiwan Liposome Additionally, working with government and industry Company partners, SRI has helped advance more than 100 drugs SRI International, an independent nonprofit into clinical trials, and more than 30 drugs onto research and development organization, recently the market. announced it had signed an agreement with Taiwan Liposome Company (TLC), a biopharmaceutical company, to begin preclinical safety and toxicology Others studies of a new cancer drug developed by TLC. European Institute of Technology The studies will be conducted in support of an IND application to the US FDA. Preclinical safety studies to Begin Operations in 2008 are necessary to generate sufficient data for IND European Institute of Technology, a flagship submission leading to future clinical trials. The university to be created by the European Union (EU), is agreement with SRI involves the preclinical testing of to begin operations in 2008, the European Commission TLC-1988, a proprietary cancer drug being developed said recently. for both chemotherapy and radiotherapy. TLC-1988 is a second-generation camptothecin analog with an The EU’s executive body adopted a proposal to efficacy and safety profile that is better than previous establish a European Institute of Technology (EIT), drugs in this class. Camptothecin is a quinoline-based vowing to provide a budget of up to 2.4 billion euro alkaloid found in the bark of Chinese camptotheca trees. (around 3.0 billion U.S. dollars) for the period 2008- 2013, to be financed by public and private sources. Under the terms of the agreement, SRI will design According to the press release, the proposed and conduct safety and toxicology studies to help organization of the EIT is in the form of a small central determine an appropriate treatment regimen (dose, governance structure and a network of “Knowledge route and frequency of drug administration) for clinical and Innovation Communities,” which will carry out trials. Following these studies, an interdisciplinary the tasks of the EIT. SRI team will manage the filing of the IND. The EIT will be a flagship for excellence in Founded in 1997 in Taipei, Taiwan, TLC is a innovation, research and higher education in Europe. biopharmaceutical company engaging in research, It will be a reference model in the way it combines development and commercialization of proprietary the worlds of academia, research and business so as to drug delivery system for improving the treatment enable Europe to face the challenges of a globalizing, of cancer, ophthalmic conditions, and infectious knowledge-based world economy more effectively. diseases. Commenting on the proposal, EC President Jose The SRI Biosciences Division a unit of SRI Manuel Barroso said the EIT is designed to attract International, an independent research and technology talent and bring together the very best actors in the development organization. The Biosciences Division knowledge triangle. performs basic research on disease mechanisms, drug discovery and the development of biologics, “Through its networks, the EIT will tear down and provides preclinical contract research and the walls between research, education and business, development services. The organization has to unlock Europe’s potential for innovation,” he developed nine drugs internally that have added.